The World Health Organization (WHO) has reported an alarming surge in cholera cases globally, with a total of 307,433 cases and 2,326 deaths recorded across 26 countries between January 1 and July 28, 2023. This data underscores the persistent and growing threat of cholera, particularly in vulnerable regions.
In a statement released on Thursday, the WHO highlighted the distribution of cholera cases across different regions, with the Eastern Mediterranean Region bearing the brunt of the outbreak, recording the highest number of cases. This was followed by significant outbreaks in the African Region, Southeast Asia, the Americas, and Europe. Notably, the Western Pacific Region has so far remained free of cholera outbreaks during this period.
The global response to cholera is currently facing a critical challenge: a severe shortage of Oral Cholera Vaccines (OCV). The demand for vaccines has drastically outpaced supply, with 18 countries requesting a staggering 105 million doses since January 2023. This demand is nearly double the total production, which stands at just 55 million doses. The shortage of vaccines is exacerbating the situation, as more countries are affected by outbreaks and require immediate intervention to prevent further spread and fatalities.
In response to the escalating crisis, the WHO classified the global cholera resurgence as a grade 3 emergency, its highest internal emergency level, in January 2023. This classification reflects the severity of the situation, characterized by the increasing number of outbreaks, their widespread geographic distribution, and the critical vaccine shortages.
The WHO continues to assess the global risk of cholera as very high. The combination of rising cases, the expanding geographic reach of the disease, and the insufficient vaccine supply has created a dire situation. Health authorities and governments around the world are urged to intensify their efforts in cholera prevention, control, and treatment to mitigate the impact of this deadly disease.
As the situation remains classified as a grade 3 emergency, the WHO and its partners are working tirelessly to mobilize resources, enhance surveillance, and improve access to life-saving interventions. However, the global community faces significant challenges in containing the outbreak, and urgent action is needed to address the vaccine shortage and strengthen public health responses to prevent further loss of life.
